Feroz Dewan - 08 Jun 2021 Form 4 Insider Report for Fortive Corp (FTV)

Reporting relationship: Director
Issuer ticker: FTV
Reported as of: 08 Jun 2021
Net transaction value: +$115,263
SEC form: 4
Accepted by SEC: 10 Jun 2021, 16:58:11 UTC
Next SEC filing: 29 Jun 2022
Source filing: View source filing
Reporting owner signature: Daniel B. Kim, as attorney-in-fact

Key filing fact

Feroz Dewan filed Form 4 for Fortive Corp (FTV) on 10 Jun 2021.

Key facts

This page summarizes Feroz Dewan's Form 4 filing for Fortive Corp (FTV).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2021, 16:58.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$115,263.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FTV transaction

Common Stock

Award

Transaction value: $0
Shares: +1,265
Change %: +9.5%
Price: $0.000000
Shares after: 14,639
Date: 08 Jun 2021
Ownership: Direct
Footnotes: F1, F2

FTV transaction

Common Stock

Award

Transaction value: $115,263
Shares: +1,615
Change %: +11%
Price: $71.37
Shares after: 16,254
Date: 08 Jun 2021
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FTV transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +3,830
Change %
Price: $0.000000
Shares after: 3,830
Date: 08 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,830
Exercise price: $72.03

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On June 8, 2021, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary of the grant date following the Reporting Person's retirement from the Board of Directors of the Issuer.

Footnote F2

In connection with the spin-off of Vontier Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment.

Footnote F3

On June 8, 2021, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $71.37, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.